Monoclonal antibodies are used to improve & suppress the immune responses in several medical conditions and to treat different diseases such as cardiovascular, cancer, and cerebrovascular diseases. The benefits of monoclonal antibodies include inhibiting cancer cell growth, detecting & killing abnormal cells directly, and delivering radioactive particles to the specific cells, thereby decreasing the risk of side effects from medication. The report provides market dynamics and trends related to the monoclonal antibodies market. The study estimates the revenue generated from the sales of monoclonal antibodies sources. The valuations comprise revenue generated from monoclonal antibodies sources such as murine, chimeric, humanized, and human.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET LANDSCAPE

CHAPTER 4: MONOCLONAL ANTIBODIES MARKET, BY SOURCE

CHAPTER 5: MONOCLONAL ANTIBODIES MARKET, BY INDICATION

CHAPTER 6: MONOCLONAL ANTIBODIES MARKET, BY END USER

CHAPTER 7: MONOCLONAL ANTIBODIES MARKET, BY REGION

CHAPTER 8: COMPANY PROFILES